Biotechnology Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland December 7, 2022
Biotechnology Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022 Annual Meeting December 7, 2022
Biotechnology Editas Medicine Announces Positive Safety and Efficacy Data from the First Two Patients Treated in the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease December 6, 2022
Biotechnology Ascendis Pharma to Initiate TransCon(TM) PTH U.S. Expanded Access Program for Adult Patients with Hypoparathyroidism December 5, 2022
Biotechnology Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting December 5, 2022
Biotechnology Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial December 5, 2022
Search
